Preventing Cytomegalovirus Infection in High-Risk Bone Marrow Transplant Patients

In this CME-certified interactive presentation, Kathleen Mullane, DO, PharmD, provides expert perspectives on optimal strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.

Kathleen Mullane, DO, PharmD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: December 13, 2017 Expired: No longer available for credit

In this downloadable slideset, Kathleen Mullane, DO, PharmD, provides expert perspectives on current and emerging strategies for preventing and managing CMV infection in patients undergoing bone marrow transplantation.

How might emerging investigational agents change the management of CMV infection in the post–hematopoietic cell transplantation setting? Here’s my take.

Roy F. Chemaly, MD Released: September 6, 2017

How has the approval of letermovir prophylaxis altered post-HCT CMV management? Here’s my take.

Genovefa A. Papanicolaou, MD Released: January 16, 2018